Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma Patients in Complete Metabolic Response

Authors

Andrew P Jallouk
Sushanth Gouni
Jason Westin
Lei Feng
Haleigh Mistry
Raphael E Steiner
Jinsu James
Mansoor Noorani
Sandra Horowitz
Nahum Puebla-Osorio
Luis E Fayad
Swaminathan P Iyer
Misha Hawkins
Christopher R Flowers
Sairah Ahmed
Loretta J Nastoupil
Partow Kebriaei
Elizabeth J Shpall
Sattva S Neelapu
Yago Nieto
Paolo Strati

Publication Date

4-1-2023

Journal

Haematologica

DOI

10.3324/haematol.2022.281954

PMID

36384251

PMCID

PMC10071112

PubMedCentral® Posted Date

11-17-2022

PubMedCentral® Full Text Version

Post-print

Keywords

Humans, Lymphoma, Large B-Cell, Diffuse, Immunotherapy, Adoptive, Biological Products, Antigens, CD19

Published Open-Access

yes

Recommended Citation

Jallouk, Andrew P; Gouni, Sushanth; Westin, Jason; et al., "Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma Patients in Complete Metabolic Response" (2023). Faculty, Staff and Student Publications. 4890.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/4890